Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study - Hensley, ML; Blessing, JA; DeGeest, K (Gynecol Oncol, 2008)
et al.